Discover the potential of BPC-157 to support your recovery and well-being
Peptide therapy involves prescription compounds that require a licensed medical provider, clinical evaluation, and laboratory monitoring
But a follow-up 2021 study, known as STEP 4, showed that within 48 weeks of no longer taking semaglutide, participants regained approximately two-thirds of their prior weight loss, while those who remained on GLP-1 drug therapy continued to lose weight
TLK199 is able to enhance the potency of various antineoplastic agents against various tumor cell lines
DMPI scientists are partnering with Heather Whitson, MD, Duke Distinguished Professor of Neuroscience and director of the Duke Center for the Study of Aging and Human Development, to research how GLP-1 medications affect aging
It is marketed as a nasal spray (0.1% and 1% solutions) for the treatment of cognitive disorders, ischemic strokes, and optic nerve neuropathies